346 related articles for article (PubMed ID: 950263)
1. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
Radó JP; Marosi J; Fischer J; Takó J; Kiss N
Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
[TBL] [Abstract][Full Text] [Related]
3. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
Radó JP; Marosi J; Borbély L; Takó J
Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
[TBL] [Abstract][Full Text] [Related]
4. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
Radó JP; Marosi J; Fischer J
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
[TBL] [Abstract][Full Text] [Related]
5. Lengthening of the duration of action of DDAVP by "ineffective" doses of clofibrate in patients with pituitary diabetes insipidus.
Radó JP; Marosi J
Endokrinologie; 1976 Jun; 67(2):220-9. PubMed ID: 954691
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the antidiuretic effect of 1-deamino-8d-arginine vasopressin (DDAVP) by glibenclamide in water-loaded healthy subjects.
Radó JP; Borbély L
Endokrinologie; 1975 Sep; 66(1):88-93. PubMed ID: 817889
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
Czakó L; Julesz J; László FA
Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
Czakó L; Mezei G; László FA
Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
[TBL] [Abstract][Full Text] [Related]
9. DDAVP in the treatment of central diabetes insipidus.
Robinson AG
N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
[TBL] [Abstract][Full Text] [Related]
10. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
[TBL] [Abstract][Full Text] [Related]
11. 1-desamino-8-D-arginine vasopressin (DDAVP) concentration test.
Radó JP
Am J Med Sci; 1978; 275(1):43-52. PubMed ID: 665711
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
Radó JP; Marosi J; Fischer J
Pharmacology; 1977; 15(1):40-5. PubMed ID: 840889
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antidiuretic and natriuretic effects of [8-lysine]vasopressin and [8-D-arginine]deaminovasopressin in conscious rats.
Skopková J; Hrbas R; Barth T
Endocrinol Exp; 1981; 15(2):129-38. PubMed ID: 6973460
[TBL] [Abstract][Full Text] [Related]
14. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
Williams TD; Dunger DB; Lyon CC; Lewis RJ; Taylor F; Lightman SL
J Clin Endocrinol Metab; 1986 Jul; 63(1):129-32. PubMed ID: 3711257
[TBL] [Abstract][Full Text] [Related]
15. [Long-term treatment of central diabetes insipidus with oral DDAVP].
Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
[TBL] [Abstract][Full Text] [Related]
16. [Experiences with the intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP)--effect of one time parenteral and intranasal applications].
Tuschy U; Meinhold J; Szeszat S
Z Gesamte Inn Med; 1983 Aug; 38(16):450-2. PubMed ID: 6636913
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin)].
Limal JM; Mugner E; Czernichow P
Arch Fr Pediatr; 1977 Dec; 34(10):965-72. PubMed ID: 610662
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
Lebacq E; David L
Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
[No Abstract] [Full Text] [Related]
19. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
[TBL] [Abstract][Full Text] [Related]
20. [The effect of vasopressin analogs on water metabolism].
László F; Laczi F; Julesz J; Baláspiri L
Z Gesamte Inn Med; 1983 Nov; 38(22):248-50. PubMed ID: 6666181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
